Sixteen percent of ALL survivors had VIPN. VIPN should be increasingly recognised as a late effect of chemotherapy, as it significantly affects physical and social function quality of life.
No takes yet. Share an insight, caveat, or question.
Tay et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: